Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL29660482 | 0.99 | WNT3A (0.34) | WNT3ATNKS2 | |
| Phosphoric Acid SCHEMBL5880378 | 0.99 | WNT3A (0.34) | WNT3ATNKS2 | |
| SCHEMBL5880375 | 0.94 | WNT3A (0.34) | WNT3ATNKS2 | |
| Hydrochloric Acid SCHEMBL5880349 | 0.92 | WNT3A (0.34) | WNT3ATNKS2 | |
| SCHEMBL7299546 | 0.76 | WNT3A (0.34) | WNT3ATNKS2 | |
| Hydrochloric Acid SCHEMBL7304498 | 0.60 | — | — | |
| SCHEMBL7299920 | 0.59 | TNKS (0.34) | WNT3ATNKS2 | |
| SCHEMBL15663037 | 0.58 | GUCY1B2 (0.34) | — | |
| SCHEMBL7296866 | 0.58 | — | — | |
| SCHEMBL7304154 | 0.57 | BACE1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6723732-B1 | 2-(3-ISOXAZOLYL)-3,6,7,9-TETRAHYDROIMIDAZO(4,5-D)PYRANO(4,3-B) PYRIDINE, PHARMACEUTICALLY ACCEPTABLE SALT OR HYDRATE THEREOF AND AQUEOUS BASE INCLUDING 1-MENTHOL, ETHANOL, AND PHOSPHATE BUFFER WITH PH OF 3 TO 5 | SHIONOGI & CO., LTD. (JP) | 2004-04-20 | — | — | US | claimed |
| EP-1132094-A1 | PERCUTANEOUSLY ADMINISTRABLE PREPARATIONS CONTAINING CEREBRAL FUNCTION ACTIVATORS | SHIONOGI & CO., LTD. (JP) | 2001-09-12 | — | — | EP | claimed |
| EP-1270578-A4 | NOVEL PROCESS FOR PRODUCING FUSED IMIDAZOPYRIDINE DERIVATIVE AND NOVEL CRYSTAL FORM | SHIONOGI & CO (JP) | 2004-11-03 | — | — | EP | disclosed |
| US-6723732-B1 | 2-(3-ISOXAZOLYL)-3,6,7,9-TETRAHYDROIMIDAZO(4,5-D)PYRANO(4,3-B) PYRIDINE, PHARMACEUTICALLY ACCEPTABLE SALT OR HYDRATE THEREOF AND AQUEOUS BASE INCLUDING 1-MENTHOL, ETHANOL, AND PHOSPHATE BUFFER WITH PH OF 3 TO 5 | SHIONOGI & CO., LTD. (JP) | 2004-04-20 | — | — | US | disclosed |
| WO-2001074821-A1 | NOVEL PROCESS FOR PRODUCING FUSED IMIDAZOPYRIDINE DERIVATIVE AND NOVEL CRYSTAL FORM | SHIONOGI & CO., LTD. (JP) | 2001-10-11 | — | — | WO | disclosed |
| EP-1132094-A1 | PERCUTANEOUSLY ADMINISTRABLE PREPARATIONS CONTAINING CEREBRAL FUNCTION ACTIVATORS | SHIONOGI & CO., LTD. (JP) | 2001-09-12 | — | — | EP | disclosed |